High-resolution chromosome ideogram representation of currently recognized genes for autism spectrum disorders

International Journal of Molecular Sciences

Volumn 16, Issue 3, 2015, Pages 6464-6495

  Butler, Merlin G ^a   Rafi, Syed K ^a   Manzardo, Ann M ^a  

^a UNIVERSITY OF KANSAS MEDICAL CENTER   (United States)

Author keywords

ASD genes; Autism; Autism spectrum disorders (ASD); Genetic evidence; High resolution chromosome ideograms

Indexed keywords

ACETYLSEROTONIN METHYLTRANSFERASE; ADENOSINE A2A RECEPTOR; ADENOSINE A3 RECEPTOR; ADENOSINE DEAMINASE; ADENOSINE KINASE; ADENYLOSUCCINATE LYASE; AMINOACYLASE; AMINOMETHYLTRANSFERASE; AMYLOID PRECURSOR PROTEIN; ANDROGEN RECEPTOR; ANGIOTENSIN 2 RECEPTOR; ARACHIDONATE 5 LIPOXYGENASE ACTIVATING PROTEIN; ARGININOSUCCINATE SYNTHASE; AROMATIC LEVO AMINO ACID DECARBOXYLASE; ATAXIN 7; BETA 2 ADRENERGIC RECEPTOR; BRAIN DERIVED NEUROTROPHIC FACTOR; CANNABINOID 1 RECEPTOR; CANNABINOID 2 RECEPTOR; CASEIN KINASE IEPSILON; CATHEPSIN B; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN BINDING PROTEIN; CYCLIN DEPENDENT KINASE INHIBITOR 1B; CYSTATHIONINE BETA SYNTHASE; DISRUPTED IN SCHIZOPRENIA 1 PROTEIN; DOUBLECORTIN; DYSTROPHIN; LIPOCORTIN 1; TRANSCRIPTION FACTOR CTCF; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ARTICLE; AUTISM; BIBLIOGRAPHIC DATABASE; CHROMOSOME HIGH RESOLUTION BANDING ANALYSIS; COMPUTER ANALYSIS; DIAGNOSTIC ACCURACY; GENE; GENE SEQUENCE; GENETIC ASSOCIATION; GENETIC DATABASE; GENETIC VARIABILITY; GENOTYPE; HUMAN; INTERVIEW; MICROARRAY ANALYSIS; NERVE CELL DIFFERENTIATION; PHENOTYPE; SEQUENCE ANALYSIS; GENETIC PREDISPOSITION; GENETICS; HUMAN CHROMOSOME;

AUTISM SPECTRUM DISORDER; CHROMOSOMES, HUMAN; GENETIC PREDISPOSITION TO DISEASE; HUMANS;

EID: 84925856980     PISSN: 16616596     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms16036464     Document Type: Article

References (57)

1. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 4th ed.; American Psychiatric Association: Washington, DC, USA, 2000.
2. Johnson, C.P.; Myers, S.M.; American Academy of Pediatrics Counsel on Children with Disablities. Identifiction and evaluation of children with autism spectrum disorders. Pediatrics 2007, 120, 1183–1215.
3. Hughes, J.R. Update on autism: A review of 1300 reports published in 2008. Epilepsy Behav. 2009, 16, 569–589.
4. Lord, C.; Risi, S.; Lambrecht, L.; Cook, E.H., Jr.; Leventhal, B.L.; DiLavore, P.C.; Pickles, A.; Rutter, M. The autism diagnostic observation schedule-generic: A standard measure of social and communication deficits associated with the spectrum of autism. J. Autism Dev. Disord. 2000, 30, 205–223.
5. Le Couteur, A.; Lord, C.; Rutter, M. Autism Diagnostic Interview-Reviewed (ADI-R); Western Psychological Services: Los Angeles, CA, USA, 2003.
6. Constantino, J.N.; Davis, S.A.; Todd, R.D.; Schindler, M.K.; Gross, M.M.; Brophy, S.L.; Metzger, L.M.; Shoushtari, C.S.; Splinter, R.; Reich, W. Validation of a brief quantitative measure of autistic traits: Comparison of the social responsiveness scale with the autism diagnostic interview-revised. J. Autism Dev. Disord. 2003, 33, 427–433.
7. Rice, C. Prevalence of autism spectrum disorders-autism and developmental disabilities monitoring network, United States, 2006. MMWR Surveill. Summ. 2009, 58, 3–8.
8. Fombonne, E. Epidemiology of autistic disorder and other pervasive developmental disorders. J. Clin. Psychiatry 2005, 66 (Suppl. 10), 3–8.
9. Kanner, L. Autistic psychopathy in childhood. Nerv. Child. 1943, 2, 217–250.
10. Rapin, I. Autistic regression and disintegrative disorder: How important the role of epilepsy? Semin. Pediatr. Neurol. 1995, 2, 278–285.
11. Geschwind, D.H.; Levitt, P. Autism spectrum disorders: Developmental disconnection syndromes. Curr. Opin. Neurobiol. 2007, 17, 103–111.
12. Kurtzke, J. Neuroepidemiology. Neurology in Clinical Practice; Bradley, W., Daroff, R., Fenichel, G., Marsden, C., Eds.; Butterworth-Heinemann: Stoneham, MA, USA, 1991; pp. 545–560.
13. Gadia, C.A.; Tuchman, R.; Rotta, N.T. Autism and pervasive developmental disorders. J. Pediatr. 2004, 80, S83–S94.
14. Butler, M.G.; Dasouki, M.J.; Zhou, X.P.; Talebizadeh, Z.; Brown, M.; Takahashi, T.N.; Miles, J.H.; Wang, C.H.; Stratton, R.; Pilarski, R.; et al. Subset of individuals with autism spectrum disorders and extreme macrocephaly associated with germline PTEN tumour suppressor gene mutations. J. Med. Genet. 2005, 42, 318–321.
15. Prontera, P.; Ottaviani, V.; Toccaceli, D.; Rogaia, D.; Ardisia, C.; Romani, R.; Stangoni, G.; Pierini, A.; Donti, E. Recurrent approximately 100 kb microdeletion in the chromosomal region 14q11.2, involving CHD8 gene, is associated with autism and macrocephaly. Am. J. Med. Genet. A 2014, 164, 3137–3141.
16. Benvenuto, A.; Moavero, R.; Alessandrelli, R.; Manzi, B.; Curatolo, P. Syndromic autism: Causes and pathogenetic pathways. World J. Pediatr. 2009, 5, 169–176.
17. Holt, R.; Monaco, A.P. Links between genetics and pathophysiology in the autism spectrum disorders. EMBO Mol. Med. 2011, 3, 438–450.
18. Campbell, D.B.; Sutcliffe, J.S.; Ebert, P.J.; Militerni, R.; Bravaccio, C.; Trillo, S.; Elia, M.; Schneider, C.; Melmed, R.; Sacco, R.; et al. A genetic variant that disrupts MET transcription is associated with autism. Proc. Natl. Acad. Sci. USA 2006, 103, 16834–16839.
19. Schaefer, G.B.; Starr, L.; Pickering, D.; Skar, G.; Dehaai, K.; Sanger, W.G. Array comparative genomic hybridization findings in a cohort referred for an autism evaluation. J. Child Neurol. 2010, 25, 1498–1503.
20. Roberts, J.L.; Hovanes, K.; Dasouki, M.; Manzardo, A.M.; Butler, M.G. Chromosomal microarray analysis of consecutive individuals with autism spectrum disorders or learning disability presenting for genetic services. Gene 2014, 535, 70–78.
21. Butler, M.G.; Usrey, K.; Roberts, J.L.; Schroeder, S.R.; Manzardo, A.M. Clinical presentation and microarray analysis of Peruvian children with atypical development and/or aberrant behavior. Genet. Res. Int. 2014, 2014, 408516.
22. Miles, J.H. Autism spectrum disorders—A genetics review. Genet. Med. 2011, 13, 278–294.
23. Liu, X.; Takumi, T. Genomic and genetic aspects of autism spectrum disorder. Biochem. Biophys. Res. Commun. 2014, 452, 244–253.
24. Cox, D.M.; Butler, M.G. The 15q11.2 BP1-BP2 microdeletion syndrome: A review. Int. J. Mol. Sci. 2015, 16, 4068–4082.
25. Hempel, M.; Rivera Brugues, N.; Wagenstaller, J.; Lederer, G.; Weitensteiner, A.; Seidel, H.; Meitinger, T.; Strom, T.M. Microdeletion syndrome 16p11.2-p12.2: Clinical and molecular characterization. Am. J. Med. Genet. A 2009, 149, 2106–2112.
26. Fernandez, B.A.; Roberts, W.; Chung, B.; Weksberg, R.; Meyn, S.; Szatmari, P.; Joseph-George, A.M.; Mackay, S.; Whitten, K.; Noble, B.; et al. Phenotypic spectrum associated with de novo and inherited deletions and duplications at 16p11.2 in individuals ascertained for diagnosis of autism spectrum disorder. J. Med. Genet. 2010, 47, 195–203.
27. Miller, D.T.; Shen, Y.; Weiss, L.A.; Korn, J.; Anselm, I.; Bridgemohan, C.; Cox, G.F.; Dickinson, H.; Gentile, J.; Harris, D.J.; et al. Microdeletion/duplication at 15q13.2q13.3 among individuals with features of autism and other neuropsychiatric disorders. J. Med. Genet. 2009, 46, 242–248.
28. Ritvo, E.R.; Jorde, L.B.; Mason-Brothers, A.; Freeman, B.J.; Pingree, C.; Jones, M.B.; McMahon, W.M.; Petersen, P.B.; Jenson, W.R.; Mo, A. The UCLA-university of Utah epidemiologic survey of autism: Recurrence risk estimates and genetic counseling. Am. J. Psychiatry 1989, 146, 1032–1036.
29. Sandin, S.; Lichtenstein, P.; Kuja-Halkola, R.; Larsson, H.; Hultman, C.M.; Reichenberg, A. The familial risk of autism. JAMA 2014, 311, 1770–1777.
30. Sebat, J.; Lakshmi, B.; Malhotra, D.; Troge, J.; Lese-Martin, C.; Walsh, T.; Yamrom, B.; Yoon, S.; Krasnitz, A.; Kendall, J.; et al. Strong association of de novo copy number mutations with autism. Science 2007, 316, 445–449.
31. Lauritsen, M.B.; Als, T.D.; Dahl, H.A.; Flint, T.J.; Wang, A.G.; Vang, M.; Kruse, T.A.; Ewald, H.; Mors, O. A genome-wide search for alleles and haplotypes associated with autism and related pervasive developmental disorders on the Faroe islands. Mol. Psychiatry 2006, 11, 37–46.
32. Ma, D.; Salyakina, D.; Jaworski, J.M.; Konidari, I.; Whitehead, P.L.; Andersen, A.N.; Hoffman, J.D.; Slifer, S.H.; Hedges, D.J.; Cukier, H.N.; et al. A genome-wide association study of autism reveals a common novel risk locus at 5p14. 1. Ann. Hum. Genet. 2009, 73, 263–273.
33. Weiss, L.A.; Arking, D.E.; Gene Discovery Project of Johns Hopkins & the Autism Consortium; Daly, M.J.; Chakravarti, A. A genome-wide linkage and association scan reveals novel loci for autism. Nature 2009, 461, 802–808.
34. Anney, R.; Klei, L.; Pinto, D.; Regan, R.; Conroy, J.; Magalhaes, T.R.; Correia, C.; Abrahams, B.S.; Sykes, N.; Pagnamenta, A.T.; et al. A genome-wide scan for common alleles affecting risk for autism. Hum. Mol. Genet. 2010, 19, 4072–4082.
35. Wang, K.; Zhang, H.; Ma, D.; Bucan, M.; Glessner, J.T.; Abrahams, B.S.; Salyakina, D.; Imielinski, M.; Bradfield, J.P.; Sleiman, P.M.; et al. Common genetic variants on 5p14.1 associate with autism spectrum disorders. Nature 2009, 459, 528–533.
36. Pinto, D.; Pagnamenta, A.T.; Klei, L.; Anney, R.; Merico, D.; Regan, R.; Conroy, J.; Magalhaes, T.R.; Correia, C.; Abrahams, B.S.; et al. Functional impact of global rare copy number variation in autism spectrum disorders. Nature 2010, 466, 368–372.
37. Pagnamenta, A.T.; Khan, H.; Walker, S.; Gerrelli, D.; Wing, K.; Bonaglia, M.C.; Giorda, R.; Berney, T.; Mani, E.; Molteni, M.; et al. Rare familial 16q21 microdeletions under a linkage peak implicate cadherin 8 (CDH8) in susceptibility to autism and learning disability. J. Med. Genet. 2011, 48, 48–54.
38. Klei, L.; Sanders, S.J.; Murtha, M.T.; Hus, V.; Lowe, J.K.; Willsey, A.J.; Moreno-De-Luca, D.; Yu, T.W.; Fombonne, E.; Geschwind, D.; et al. Common genetic variants, acting additively, are a major source of risk for autism. Mol. Autism 2012, 3, 9.
39. Campbell, M.G.; Kohane, I.S.; Kong, S.W. Pathway-based outlier method reveals heterogeneous genomic structure of autism in blood transcriptome. BMC Med. Genomics 2013, 6, 34.
40. Jiang, Y.H.; Yuen, R.K.; Jin, X.; Wang, M.; Chen, N.; Wu, X.; Ju, J.; Mei, J.; Shi, Y.; He, M.; et al. Detection of clinically relevant genetic variants in autism spectrum disorder by whole-genome sequencing. Am. J. Hum. Genet. 2013, 93, 249–263.
41. Huguet, G.; Ey, E.; Bourgeron, T. The genetic landscapes of autism spectrum disorders. Ann. Rev. Genomics Hum. Genet. 2013, 14, 191–213.
42. Correia, C.; Oliveira, G.; Vicente, A.M. Protein interaction networks reveal novel autism risk genes within gwas statistical noise. PLoS One 2014, 9, e112399.
43. Merikangas, A.K.; Segurado, R.; Heron, E.A.; Anney, R.J.; Paterson, A.D.; Cook, E.H.; Pinto, D.; Scherer, S.W.; Szatmari, P.; Gill, M.; et al. The phenotypic manifestations of rare genic CNVs in autism spectrum disorder. Mol. Psychiatry 2014, doi:10.1038/mp.2014.150.
44. Lossifov, I.; O’Roak, B.J.; Sanders, S.J.; Ronemus, M.; Krumm, N.; Levy, D.; Stessman, H.A.; Witherspoon, K.T.; Vives, L.; Patterson, K.E.; et al. The contribution of de novo coding mutations to autism spectrum disorder. Nature 2014, 515, 216–221.
45. Goldani, A.A.S.; Downs, S.R.; Widjaja, F.; Lawton, B.; Hendren, R.L. Biomarkers in autism. Front. Psychiatry 2014, 5, 100.
46. Ch’ng, C.; Kwok, W.; Rogic, S.; Pavlidis, P. Meta-analysis of gene expression in autism spectrum disorder. 2015, doi:10.1002/aur.1475.
47. Uddin, M.; Tammimies, K.; Pellecchia, G.; Alipanahi, B.; Hu, P.; Wang, Z.; Pinto, D.; Lau, L.; Nalpathamkalam, T.; Marshall, C.R.; et al. Brain-expressed exons under purifying selection are enriched for de novo mutations in autism spectrum disorder. Nat. Genet. 2014, 46, 742–747.
48. De Rubeis, S.; He, X.; Goldberg, A.P.; Poultney, C.S.; Samocha, K.; Cicek, A.E.; Kou, Y.; Liu, L.; Fromer, M.; Walker, S.; et al. Synaptic, transcriptional and chromatin genes disrupted in autism. Nature 2014, 515, 209–215.
49. Hadley, D.; Wu, Z.L.; Kao, C.; Kini, A.; Mohamed-Hadley, A.; Thomas, K.; Vazquez, L.; Qiu, H.; Mentch, F.; Pellegrino, R.; et al. The impact of the metabotropic glutamate receptor and other gene family interaction networks on autism. Nat. Commun. 2014, doi:10.1038/ncomms5074.
50. Butler, M.G.; Rafi, S.K.; Hossain, W.; Stephan, D.A.; Manzardo, A.M. Whole exome sequencing in females with autism implicates novel and candidate genes. Int. J. Mol. Sci. 2015, 16, 1312–1335.
51. Yuen, R.K.; Thiruvahindrapuram, B.; Merico, D.; Walker, S.; Tammimies, K.; Hoang, N.; Chrysler, C.; Nalpathamkalam, T.; Pellecchia, G.; Liu, Y.; et al. Whole-genome sequencing of quartet families with autism spectrum disorder. Nat. Med. 2015, 21, 185–191.
52. Willsey, JA; State, MW. Autism spectrum disorders: From genes to neurobiology. Curr. Opin. Neurobiol. 2015, 30, 92–99.
53. Hormozdiari, F.; Penn, O.; Borenstein, E.; Eichler, E.E. The discovery of integrated gene networks for autism and related disorders. Genome Res. 2015, 25, 142–154.
54. Butler, M.G.; Youngs, E.L.; Roberts, J.L.; Hellings, J.A. Assessment and treatment in autism spectrum disorders: A focus on genetics and psychiatry. Autism Res. Treat. 2012, doi:10.1155/2012/242537.
55. Herman, G.E.; Henninger, N.; Ratliff-Schaub, K.; Pastore, M.; Fitzgerald, S.; McBride, K.L. Genetic testing in autism: How much is enough? Genet. Med. 2007, 9, 268–274.
56. Butler, M.G. Prader-willi syndrome: Obesity due to genomic imprinting. Curr. Genomics 2011, 12, 204–215.
57. Dhillon, S.; Hellings, J.A.; Butler, M.G. Genetics and mitochondrial abnormalities in autism spectrum disorders: A review. Curr. Genomics 2011, 12, 322–332.